Matches in Wikidata for { <http://www.wikidata.org/entity/Q66029094> ?p ?o ?g. }
Showing items 1 to 47 of
47
with 100 items per page.
- Q66029094 description "clinical trial" @default.
- Q66029094 description "ensayu clínicu" @default.
- Q66029094 description "klinisch onderzoek" @default.
- Q66029094 description "клінічне випробування" @default.
- Q66029094 name "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 name "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 type Item @default.
- Q66029094 label "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 label "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 prefLabel "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 prefLabel "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients Wi" @default.
- Q66029094 P1050 Q66029094-AD20D9B3-15A9-480C-A84A-750E82E63BE5 @default.
- Q66029094 P1132 Q66029094-EB7916BC-FBCC-4C17-9E99-4DC37BB72191 @default.
- Q66029094 P1476 Q66029094-B2530A4F-DF7E-434F-ADF4-851E0F3DCF83 @default.
- Q66029094 P17 Q66029094-0F2DFC42-A674-4EDA-A792-288B7DC18D49 @default.
- Q66029094 P17 Q66029094-1F6833E9-E31B-4737-9B03-297660DB599B @default.
- Q66029094 P17 Q66029094-3290EB21-DAFA-47CD-90A0-C648E8EE1899 @default.
- Q66029094 P17 Q66029094-7C6BE491-9EDF-4F73-99F5-EBD05FB9CF53 @default.
- Q66029094 P17 Q66029094-D0840206-61CB-4B84-A3AD-F474149CC8DC @default.
- Q66029094 P17 Q66029094-D2BCCA70-D2A1-4B0A-A3A8-4ED6E8E15232 @default.
- Q66029094 P2899 Q66029094-DE1789AD-3174-4F35-8A0C-EC30754D5FD2 @default.
- Q66029094 P3098 Q66029094-17C5089D-0FEB-4883-A338-BBD3305E60D6 @default.
- Q66029094 P31 Q66029094-61E8471B-4F61-42B0-B940-D6EF2CA7D331 @default.
- Q66029094 P4135 Q66029094-E642BFC1-1B6B-4443-9885-74BD1E7DCF6E @default.
- Q66029094 P580 Q66029094-7E6AD6FD-B82C-4342-B519-0D35EC3FE4ED @default.
- Q66029094 P582 Q66029094-F6CA1D61-C6A8-40B6-B2D7-B1216038CE35 @default.
- Q66029094 P6099 Q66029094-918BEA96-FA0D-4702-9E83-9317CE338BD0 @default.
- Q66029094 P6153 Q66029094-12AD5E00-E026-4DC0-9133-EE588761E55D @default.
- Q66029094 P8363 Q66029094-76A2F9E0-4B5C-4E96-9B75-CC0F4C05ED4C @default.
- Q66029094 P1050 Q11085 @default.
- Q66029094 P1132 "+254" @default.
- Q66029094 P1476 "A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Exploratory Study of NS 2330 (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations (Study for Proof of Concept in ADVAnced Parkinson Disease of NS 2330 / ADVANS)" @default.
- Q66029094 P17 Q142 @default.
- Q66029094 P17 Q145 @default.
- Q66029094 P17 Q183 @default.
- Q66029094 P17 Q29 @default.
- Q66029094 P17 Q40 @default.
- Q66029094 P17 Q55 @default.
- Q66029094 P2899 "+42" @default.
- Q66029094 P3098 "NCT00148512" @default.
- Q66029094 P31 Q30612 @default.
- Q66029094 P4135 "+80" @default.
- Q66029094 P580 "2003-03-01T00:00:00Z" @default.
- Q66029094 P582 "2005-02-01T00:00:00Z" @default.
- Q66029094 P6099 Q42824440 @default.
- Q66029094 P6153 Q699532 @default.
- Q66029094 P8363 Q78089383 @default.